Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension

NCT02842359 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Irbesartan/atorvastatin fixed dose combination
DRUG: Irbesartan SR47436
DRUG: Atorvastatin

Sponsor

Sanofi